Did you know that bacteria have antibacterial properties? Its true. We spoke to Dr Catherine O’neill CEO of Skinbiotix Plc (LON:SBTX) who said, ‘Its worth remembering that penicillin, one of
Medications and treatment plans are designed based on averages, but not everyone is average; a treatment that works for one might not work for another. In the new wave of
OptiBiotix Health PLC (LON:OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, and diabetes has announced the successful launch of its SlimBiome® and LPLDL® products at Supply Side West in Las Vegas, on 27-28 September 2017. The exhibition provided the opportunity to connect with 16,500
OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, provides the following technical, regulatory and commercial update on its
Stephen O’Hara, Chief Executive Officer of OptiBiotix LON:OPTI, said: “We are pleased to announce this strategic partnership with Bened Biomedical and see a strong rationale for both companies to work
The quality, quantity, and composition of the bacteria in your gut have enormous influence on your brain. Dr. David Perlmutter explores this phenomenon in great detail in his new book,
OptiBiotix Health PLC (AIM:OPTI), a life sciences business developing compounds to tackle obesity, cardiovascular disease and diabetes, has announced it has been invited to present its research and commercial developments at the 18th edition of Expoquimia-World Chemical Summit (‘Expoquimia’) in Barcelona, Spain, on 5 October 2017. Expoquimia
OptiBiotix Health plc (LON:OPTI), a life sciences business developing products to tackle obesity, high cholesterol and diabetes, announces that Stephen O’Hara, CEO of Optibiotix, will be presenting at an investor evening hosted by Turner Pope Investments Ltd (“TPI”). The event will be held on Tuesday 19 September 2017
Stephen O’Hara, CEO of OptiBiotix LON:OPTI, commented on the Manufacturing Agreement with Tata Chemicals: “We are pleased to report this Agreement with Tata Chemicals which creates the opportunity to scale
Stephen O’Hara, CEO of OptiBiotix PLC LON:OPTI commented: “OptiBiotix has made significant progress in the last six months developing a pipeline of innovative products with a strong scientific and clinical
© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
